vs
Organogenesis Holdings Inc.（ORGO）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是Rapid7, Inc.的1.0倍（$225.6M vs $217.4M），Organogenesis Holdings Inc.净利率更高（19.4% vs 1.4%，领先17.9%），Organogenesis Holdings Inc.同比增速更快（78.1% vs 0.5%），Rapid7, Inc.自由现金流更多（$36.4M vs $34.8M），过去两年Organogenesis Holdings Inc.的营收复合增速更高（43.2% vs 3.0%）
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
ORGO vs RPD — 直观对比
营收规模更大
ORGO
是对方的1.0倍
$217.4M
营收增速更快
ORGO
高出77.6%
0.5%
净利率更高
ORGO
高出17.9%
1.4%
自由现金流更多
RPD
多$1.7M
$34.8M
两年增速更快
ORGO
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $225.6M | $217.4M |
| 净利润 | $43.7M | $3.1M |
| 毛利率 | — | 68.9% |
| 营业利润率 | 28.1% | 1.0% |
| 净利率 | 19.4% | 1.4% |
| 营收同比 | 78.1% | 0.5% |
| 净利润同比 | 469.5% | 44.1% |
| 每股收益（稀释后） | $0.31 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ORGORPD
| Q4 25 | $225.6M | $217.4M | ||
| Q3 25 | $150.9M | $218.0M | ||
| Q2 25 | $101.0M | $214.2M | ||
| Q1 25 | $86.7M | $210.3M | ||
| Q4 24 | $126.7M | $216.3M | ||
| Q3 24 | $115.2M | $214.7M | ||
| Q2 24 | $130.2M | $208.0M | ||
| Q1 24 | $110.0M | $205.1M |
净利润ORGORPD
| Q4 25 | $43.7M | $3.1M | ||
| Q3 25 | $21.6M | $9.8M | ||
| Q2 25 | $-9.4M | $8.3M | ||
| Q1 25 | $-18.8M | $2.1M | ||
| Q4 24 | $7.7M | $2.2M | ||
| Q3 24 | $12.3M | $15.4M | ||
| Q2 24 | $-17.0M | $6.5M | ||
| Q1 24 | $-2.1M | $1.4M |
毛利率ORGORPD
| Q4 25 | — | 68.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.6% | ||
| Q1 25 | 72.6% | 71.7% | ||
| Q4 24 | 75.5% | 69.5% | ||
| Q3 24 | 76.7% | 70.6% | ||
| Q2 24 | 77.6% | 70.7% | ||
| Q1 24 | 73.9% | 70.3% |
营业利润率ORGORPD
| Q4 25 | 28.1% | 1.0% | ||
| Q3 25 | 13.7% | 2.7% | ||
| Q2 25 | -12.5% | 1.6% | ||
| Q1 25 | -30.9% | -0.0% | ||
| Q4 24 | 8.1% | 3.4% | ||
| Q3 24 | 5.4% | 6.0% | ||
| Q2 24 | -10.7% | 2.5% | ||
| Q1 24 | -3.5% | 4.7% |
净利率ORGORPD
| Q4 25 | 19.4% | 1.4% | ||
| Q3 25 | 14.3% | 4.5% | ||
| Q2 25 | -9.3% | 3.9% | ||
| Q1 25 | -21.7% | 1.0% | ||
| Q4 24 | 6.1% | 1.0% | ||
| Q3 24 | 10.7% | 7.2% | ||
| Q2 24 | -13.1% | 3.1% | ||
| Q1 24 | -1.9% | 0.7% |
每股收益（稀释后）ORGORPD
| Q4 25 | $0.31 | $0.05 | ||
| Q3 25 | $0.11 | $0.15 | ||
| Q2 25 | $-0.10 | $0.13 | ||
| Q1 25 | $-0.17 | $0.03 | ||
| Q4 24 | $0.05 | $0.08 | ||
| Q3 24 | $0.09 | $0.21 | ||
| Q2 24 | $-0.13 | $0.09 | ||
| Q1 24 | $-0.02 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.7M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $300.1M | $154.7M |
| 总资产 | $598.7M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ORGORPD
| Q4 25 | $93.7M | $474.7M | ||
| Q3 25 | $63.7M | $407.1M | ||
| Q2 25 | $73.1M | $511.7M | ||
| Q1 25 | $110.0M | $493.5M | ||
| Q4 24 | $135.6M | $521.7M | ||
| Q3 24 | $94.3M | $443.7M | ||
| Q2 24 | $89.9M | $442.6M | ||
| Q1 24 | $88.6M | $411.7M |
总债务ORGORPD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — | ||
| Q1 24 | $65.2M | — |
股东权益ORGORPD
| Q4 25 | $300.1M | $154.7M | ||
| Q3 25 | $255.1M | $127.2M | ||
| Q2 25 | $233.2M | $90.4M | ||
| Q1 25 | $242.9M | $52.7M | ||
| Q4 24 | $262.9M | $17.7M | ||
| Q3 24 | $278.5M | $-5.1M | ||
| Q2 24 | $263.5M | $-52.6M | ||
| Q1 24 | $278.0M | $-86.4M |
总资产ORGORPD
| Q4 25 | $598.7M | $1.7B | ||
| Q3 25 | $509.8M | $1.7B | ||
| Q2 25 | $461.1M | $1.6B | ||
| Q1 25 | $467.4M | $1.6B | ||
| Q4 24 | $497.9M | $1.7B | ||
| Q3 24 | $446.3M | $1.6B | ||
| Q2 24 | $443.2M | $1.5B | ||
| Q1 24 | $458.5M | $1.5B |
负债/权益比ORGORPD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.4M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $34.8M | $36.4M |
| 自由现金流率自由现金流/营收 | 15.4% | 16.8% |
| 资本支出强度资本支出/营收 | 2.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.90× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $-24.5M | $146.2M |
8季度趋势，按日历期对齐
经营现金流ORGORPD
| Q4 25 | $39.4M | $37.6M | ||
| Q3 25 | $3.1M | $39.0M | ||
| Q2 25 | $-32.9M | $47.5M | ||
| Q1 25 | $-19.9M | $29.8M | ||
| Q4 24 | $10.9M | $63.8M | ||
| Q3 24 | $8.7M | $44.0M | ||
| Q2 24 | $4.7M | $32.9M | ||
| Q1 24 | $-10.2M | $31.1M |
自由现金流ORGORPD
| Q4 25 | $34.8M | $36.4M | ||
| Q3 25 | $844.0K | $34.8M | ||
| Q2 25 | $-36.5M | $46.6M | ||
| Q1 25 | $-23.6M | $28.4M | ||
| Q4 24 | $7.6M | $62.6M | ||
| Q3 24 | $6.1M | $42.6M | ||
| Q2 24 | $2.9M | $32.6M | ||
| Q1 24 | $-12.4M | $30.4M |
自由现金流率ORGORPD
| Q4 25 | 15.4% | 16.8% | ||
| Q3 25 | 0.6% | 16.0% | ||
| Q2 25 | -36.1% | 21.8% | ||
| Q1 25 | -27.2% | 13.5% | ||
| Q4 24 | 6.0% | 28.9% | ||
| Q3 24 | 5.3% | 19.9% | ||
| Q2 24 | 2.2% | 15.7% | ||
| Q1 24 | -11.3% | 14.8% |
资本支出强度ORGORPD
| Q4 25 | 2.1% | 0.5% | ||
| Q3 25 | 1.5% | 1.9% | ||
| Q2 25 | 3.6% | 0.4% | ||
| Q1 25 | 4.2% | 0.6% | ||
| Q4 24 | 2.7% | 0.5% | ||
| Q3 24 | 2.2% | 0.6% | ||
| Q2 24 | 1.4% | 0.1% | ||
| Q1 24 | 2.0% | 0.3% |
现金转化率ORGORPD
| Q4 25 | 0.90× | 12.01× | ||
| Q3 25 | 0.14× | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | 1.43× | 29.36× | ||
| Q3 24 | 0.71× | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ORGO
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
